BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31992595)

  • 1. Antisense oligonucleotides targeting
    Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
    J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
    Yu J; Canalis E
    J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
    Yu J; Schilling L; Eller T; Canalis E
    J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
    Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
    J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
    Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
    J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
    Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
    Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis.
    Canalis E; Schilling L; Yu J; Denker E
    J Biol Chem; 2024 Feb; 300(2):105613. PubMed ID: 38159855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
    Canalis E; Sanjay A; Yu J; Zanotti S
    Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.
    Yu J; Zanotti S; Schilling L; Schoenherr C; Economides AN; Sanjay A; Canalis E
    Am J Pathol; 2018 Jun; 188(6):1430-1446. PubMed ID: 29545197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lateral meningocele syndrome mutation causes marked osteopenia in mice.
    Canalis E; Yu J; Schilling L; Yee SP; Zanotti S
    J Biol Chem; 2018 Sep; 293(36):14165-14177. PubMed ID: 30042232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
    Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
    J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antisense oligonucleotides to target Notch3 in skeletal cells.
    Canalis E; Carrer M; Eller T; Schilling L; Yu J
    PLoS One; 2022; 17(5):e0268225. PubMed ID: 35536858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice.
    Yu J; Siebel CW; Schilling L; Canalis E
    J Cell Physiol; 2020 Jan; 235(1):210-220. PubMed ID: 31188489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.
    Canalis E; Zanotti S
    Curr Osteoporos Rep; 2016 Aug; 14(4):126-31. PubMed ID: 27241678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH2 Hajdu-Cheney Mutations Escape SCF
    Fukushima H; Shimizu K; Watahiki A; Hoshikawa S; Kosho T; Oba D; Sakano S; Arakaki M; Yamada A; Nagashima K; Okabe K; Fukumoto S; Jimi E; Bigas A; Nakayama KI; Nakayama K; Aoki Y; Wei W; Inuzuka H
    Mol Cell; 2017 Nov; 68(4):645-658.e5. PubMed ID: 29149593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton.
    Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T
    Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture healing in a mouse model of Hajdu-Cheney-Syndrome with high turnover osteopenia results in decreased biomechanical stability.
    Ballhause TM; Jiang S; Xie W; Sevecke J; Dowling C; Dust T; Brandt S; Mertens PR; Yorgan TA; Schinke T; Frosch KH; Baranowsky A; Keller J
    Sci Rep; 2023 Jul; 13(1):11418. PubMed ID: 37452111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH2 sensitizes the chondrocyte to the inflammatory response of tumor necrosis factor α.
    Canalis E; Yu J; Singh V; Mocarska M; Schilling L
    J Biol Chem; 2023 Dec; 299(12):105372. PubMed ID: 37865314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
    Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
    Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hajdu-Cheney syndrome: a review.
    Canalis E; Zanotti S
    Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.